AMG 160: A PSMA-targeted, bispecific T-cell engager immune therapy for mCRPC

Estimate of the 2-year oncology workload generated by each new patient: A real-world study

Amivantamab lazertinib and other novel combinations in EGFR positive advanced NSCLC

Impact of COVID-19 pandemic on cancer care: A global collaborative study

MonarchE: Abemaciclib plus endocrine therapy in high-risk early breast cancer

LungART: Radiotherapy after surgery for patients with non small cell lung cancer

Personalised molecularly matched therapies for carcinomas of unknown primary

Impact of COVID-19 on oncology professionals

SOLO-1: Olaparib or placebo for patients with newly diagnosed BRCA-mutated advanced ovarian cancer

Pembrolizumab vs cetuximab with radiotherapy in locally advanced HNSCC

The emerging importance of studying immune regulatory molecule expression patterns

BOUNCE project: Studying patient resilience in breast cancer